A group of researchers from the Royal Melbourne Hospital, University of Melbourne, Peter MacCallum Cancer Centre and RMIT University has received a MRFF grant worth more than $2.9 million dollars to develop and implement digital health solutions for surveillance of the quality of antimicrobial use in healthcare.
Antimicrobial resistance has become a global health challenge, highlighting a need to promote the safe use of antimicrobial medications. A sophisticated monitoring system is needed across healthcare providers Australia, including aged care, hospitals and veterinary practices. The project will bring together a multidisciplinary team of researchers to establish a new research platform for surveillance of antimicrobial use across health settings.
The RMH, Doherty Institute and the University of Melbourne infectious diseases physician and researcher Professor Karin Thursky will lead this project. Professor Thursky is an infectious diseases physician and health services researcher, has played a leading role in developing local and national antimicrobial stewardship initiatives, focusing particularly on the use of digital health technologies.